Claire Gervais
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 06, 2025
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 19, 2025
Opioid-induced constipation: Update on management and treatment
Journal: Bulletin du cancer
Published: November 23, 2024
Real-world evaluation of nivolumab utilization in adjuvant treatment of localized muscle-invasive urothelial carcinoma.
Journal: The French journal of urology
Published: June 13, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.
Journal: NPJ precision oncology
Published: March 03, 2024
Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies
Journal: Bulletin du cancer
Published: November 01, 2022
Future treatment options in metastatic clear cell renal cell carcinoma.
Journal: Bulletin du cancer
Published: June 27, 2022
Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers.
Journal: British journal of cancer
Published: March 01, 2022
Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohort.
Journal: Gynecologic oncology
Published: February 27, 2022
Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer.
Journal: Gynecologic oncology
Published: September 27, 2021
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 08, 2021
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study.
Journal: EBioMedicine
Published: April 07, 2021
Last Updated: 09/26/2026